By Will Feuer

 

Healthcare product and pharmaceuticals manufacturer Perrigo said the U.S. Food and Drug Administration has approved the company's oral contraceptive Opill for over-the-counter use in all ages.

Opill will be the first-ever birth control pill available over-the-counter without needing a doctor's prescription in the U.S. The oral contraceptive will be sold in stores and online at leading retailers across the U.S. early in the first quarter of 2024, Perrigo said.

Shares rose 5.8% to $35.00 in premarket trading Thursday.

 

Write to Will Feuer at Will.Feuer@wsj.com

 

(END) Dow Jones Newswires

July 13, 2023 09:10 ET (13:10 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Perrigo Company Plc Irel... (NYSE:PRGO)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Perrigo Company Plc Irel... Charts.
Perrigo Company Plc Irel... (NYSE:PRGO)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Perrigo Company Plc Irel... Charts.